ANXA2 and metastatic malignant neoplasm in the lymph nodes: The high expression rate of ANXA2 in the lymph node metastasis group was 94.7 % (18/19), which was significantly higher than the negative lymph node metastasis group (58.0 % [29/50]; p < 0.05) (Table 2).